UK
AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine
May 19, 2020Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma
AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …
NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population
May 7, 2020Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer
NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …
MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments
May 5, 2020Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
Top Ten most popular articles on Pharmafile.com this week
May 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs
The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …
Bayer’s Vitrakvi becomes first tumour-agnostic therapy approved by NICE for NHS patients with NTRK fusion+ cancer
April 21, 2020Manufacturing and Production, Sales and Marketing Bayer, Cancer, NICE, UK, Vitrakvi, tumour agnostic
Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) has just been recommended by NICE in the treatment of advanced neurotrophic tyrosine receptor …
British Health Secretary says more patients with COVID-19 are needed for clinical trials
April 6, 2020Sales and Marketing COVID-19, UK, clinical trials, coronavirus
Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials …
The April 2020 issue of Pharmafocus is available to read free online now!
April 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data
The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
NICE promotes Professor Gillian Leng as its new Chief Executive
March 18, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma
NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …
NHS England to supply HIV prevention drug PrEP with £16m government investment
March 16, 2020Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma
NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …
NICE shoots down Dupixent for severe asthma
March 9, 2020Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma
NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …
NICE recommends avatrombopag to treat thrombocytopenia in chronic liver disease
March 4, 2020Research and Development Avatrombopag, NHS, NICE, UK, chronic liver disease
UK drug watchdog NICE has announced its final draft guidance recommending avatrombopag for routine use on the NHS in England …
GW Pharma takes back control of UK Sativex sales from Bayer
March 2, 2020Sales and Marketing Bayer, GW Pharma, Sativex, UK
British firm GW Pharmaceuticals has revealed that it plans to reclaim the commercialisation rights to market its cannabis-based multiple sclerosis …
Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting
February 28, 2020Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma
UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …
The March 2020 issue of Pharmafocus is available to read free online now!
February 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes
The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
Scotland’s life sciences sector on track to break $8 billion by 2025
February 25, 2020Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma
A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …
Latest content
